Attention: World-2DPAGE is no longer maintained.
[Click to access protein entry]
Spot: 2D-000C9R (csf_human)
pI: 6.68 Mw: 26527
%vol: 0.175973 %od: 0.21683
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9R (csf_human)
pI: 6.68 Mw: 26527
%vol: 0.175973 %od: 0.21683
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAW (csf_human)
pI: 8.10 Mw: 24204
%vol: 0.152726 %od: 0.311562
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAW (csf_human)
pI: 8.10 Mw: 24204
%vol: 0.152726 %od: 0.311562
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAN (csf_human)
pI: 7.40 Mw: 23379
%vol: 0.279219 %od: 2.42095
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAN (csf_human)
pI: 7.40 Mw: 23379
%vol: 0.279219 %od: 2.42095
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9I (csf_human)
pI: 5.88 Mw: 27192
%vol: 0.0240258 %od: 0.00987374
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9I (csf_human)
pI: 5.88 Mw: 27192
%vol: 0.0240258 %od: 0.00987374
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBG (csf_human)
pI: 6.82 Mw: 23612
%vol: 0.127532 %od: 0.0555577
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBG (csf_human)
pI: 6.82 Mw: 23612
%vol: 0.127532 %od: 0.0555577
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8Y (csf_human)
pI: 5.48 Mw: 28361
%vol: 0.0175324 %od: 0.00813604
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8Y (csf_human)
pI: 5.48 Mw: 28361
%vol: 0.0175324 %od: 0.00813604
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9C (csf_human)
pI: 6.36 Mw: 27394
%vol: 0.0555843 %od: 0.0359003
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9C (csf_human)
pI: 6.36 Mw: 27394
%vol: 0.0555843 %od: 0.0359003
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA9 (csf_human)
pI: 6.35 Mw: 25307
%vol: 0.0935059 %od: 0.121603
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA9 (csf_human)
pI: 6.35 Mw: 25307
%vol: 0.0935059 %od: 0.121603
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAX (csf_human)
pI: 6.18 Mw: 24324
%vol: 0.0405193 %od: 0.0420528
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAX (csf_human)
pI: 6.18 Mw: 24324
%vol: 0.0405193 %od: 0.0420528
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CC1 (csf_human)
pI: 7.28 Mw: 22502
%vol: 0.221038 %od: 0.288142
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CC1 (csf_human)
pI: 7.28 Mw: 22502
%vol: 0.221038 %od: 0.288142
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA0 (csf_human)
pI: 7.05 Mw: 26006
%vol: 0.0370128 %od: 0.0203462
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA0 (csf_human)
pI: 7.05 Mw: 26006
%vol: 0.0370128 %od: 0.0203462
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA1 (csf_human)
pI: 6.05 Mw: 25686
%vol: 0.022857 %od: 0.0209035
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA1 (csf_human)
pI: 6.05 Mw: 25686
%vol: 0.022857 %od: 0.0209035
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBP (csf_human)
pI: 8.14 Mw: 23264
%vol: 0.172337 %od: 0.099825
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBP (csf_human)
pI: 8.14 Mw: 23264
%vol: 0.172337 %od: 0.099825
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9N (csf_human)
pI: 5.81 Mw: 26924
%vol: 0.0518179 %od: 0.0143105
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9N (csf_human)
pI: 5.81 Mw: 26924
%vol: 0.0518179 %od: 0.0143105
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA7 (csf_human)
pI: 6.20 Mw: 25814
%vol: 0.0372725 %od: 0.0161042
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA7 (csf_human)
pI: 6.20 Mw: 25814
%vol: 0.0372725 %od: 0.0161042
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CCN (csf_human)
pI: 7.68 Mw: 21464
%vol: 0.0574026 %od: 0.0280198
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CCN (csf_human)
pI: 7.68 Mw: 21464
%vol: 0.0574026 %od: 0.0280198
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C91 (csf_human)
pI: 5.76 Mw: 28221
%vol: 0.0172726 %od: 0.00643484
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C91 (csf_human)
pI: 5.76 Mw: 28221
%vol: 0.0172726 %od: 0.00643484
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBH (csf_human)
pI: 7.07 Mw: 23496
%vol: 0.196492 %od: 0.209858
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBH (csf_human)
pI: 7.07 Mw: 23496
%vol: 0.196492 %od: 0.209858
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAV (csf_human)
pI: 7.08 Mw: 24445
%vol: 0.112597 %od: 0.138551
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAV (csf_human)
pI: 7.08 Mw: 24445
%vol: 0.112597 %od: 0.138551
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBN (csf_human)
pI: 7.67 Mw: 22769
%vol: 0.158051 %od: 0.330302
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBN (csf_human)
pI: 7.67 Mw: 22769
%vol: 0.158051 %od: 0.330302
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CB7 (csf_human)
pI: 6.48 Mw: 23847
%vol: 0.0641555 %od: 0.0508654
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CB7 (csf_human)
pI: 6.48 Mw: 23847
%vol: 0.0641555 %od: 0.0508654
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA2 (csf_human)
pI: 6.10 Mw: 25750
%vol: 0.0435063 %od: 0.0399914
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA2 (csf_human)
pI: 6.10 Mw: 25750
%vol: 0.0435063 %od: 0.0399914
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAP (csf_human)
pI: 6.11 Mw: 24811
%vol: 0.0363634 %od: 0.0235587
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAP (csf_human)
pI: 6.11 Mw: 24811
%vol: 0.0363634 %od: 0.0235587
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9Q (csf_human)
pI: 6.40 Mw: 26724
%vol: 0.096233 %od: 0.0547887
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9Q (csf_human)
pI: 6.40 Mw: 26724
%vol: 0.096233 %od: 0.0547887
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CC0 (csf_human)
pI: 8.44 Mw: 22449
%vol: 0.097402 %od: 0.150569
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CC0 (csf_human)
pI: 8.44 Mw: 22449
%vol: 0.097402 %od: 0.150569
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBD (csf_human)
pI: 6.98 Mw: 23612
%vol: 0.226752 %od: 0.395977
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBD (csf_human)
pI: 6.98 Mw: 23612
%vol: 0.226752 %od: 0.395977
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C90 (csf_human)
pI: 6.04 Mw: 28361
%vol: 0.0425972 %od: 0.0245541
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C90 (csf_human)
pI: 6.04 Mw: 28361
%vol: 0.0425972 %od: 0.0245541
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9P (csf_human)
pI: 6.51 Mw: 26724
%vol: 0.0561039 %od: 0.052406
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9P (csf_human)
pI: 6.51 Mw: 26724
%vol: 0.0561039 %od: 0.052406
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9E (csf_human)
pI: 5.76 Mw: 27327
%vol: 0.0197402 %od: 0.00719904
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9E (csf_human)
pI: 5.76 Mw: 27327
%vol: 0.0197402 %od: 0.00719904
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAU (csf_human)
pI: 6.97 Mw: 24566
%vol: 0.0961033 %od: 0.0519971
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAU (csf_human)
pI: 6.97 Mw: 24566
%vol: 0.0961033 %od: 0.0519971
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA4 (csf_human)
pI: 6.31 Mw: 25814
%vol: 0.0646751 %od: 0.0386212
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA4 (csf_human)
pI: 6.31 Mw: 25814
%vol: 0.0646751 %od: 0.0386212
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9O (csf_human)
pI: 6.27 Mw: 26857
%vol: 0.0445452 %od: 0.023622
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9O (csf_human)
pI: 6.27 Mw: 26857
%vol: 0.0445452 %od: 0.023622
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA5 (csf_human)
pI: 6.41 Mw: 25686
%vol: 0.290648 %od: 0.465256
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA5 (csf_human)
pI: 6.41 Mw: 25686
%vol: 0.290648 %od: 0.465256
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBY (csf_human)
pI: 8.12 Mw: 22343
%vol: 0.192207 %od: 0.583529
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBY (csf_human)
pI: 8.12 Mw: 22343
%vol: 0.192207 %od: 0.583529
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAB (csf_human)
pI: 6.53 Mw: 25182
%vol: 0.252206 %od: 0.476047
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAB (csf_human)
pI: 6.53 Mw: 25182
%vol: 0.252206 %od: 0.476047
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAE (csf_human)
pI: 6.19 Mw: 25182
%vol: 0.0538958 %od: 0.0552389
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAE (csf_human)
pI: 6.19 Mw: 25182
%vol: 0.0538958 %od: 0.0552389
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBO (csf_human)
pI: 6.46 Mw: 23264
%vol: 0.0376621 %od: 0.00951111
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBO (csf_human)
pI: 6.46 Mw: 23264
%vol: 0.0376621 %od: 0.00951111
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9S (csf_human)
pI: 6.91 Mw: 26592
%vol: 0.0399998 %od: 0.0251261
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9S (csf_human)
pI: 6.91 Mw: 26592
%vol: 0.0399998 %od: 0.0251261
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8R (csf_human)
pI: 5.10 Mw: 29000
%vol: 0.0170129 %od: 0.0048529
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8R (csf_human)
pI: 5.10 Mw: 29000
%vol: 0.0170129 %od: 0.0048529
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8U (csf_human)
pI: 5.80 Mw: 28643
%vol: 0.0275323 %od: 0.0157658
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8U (csf_human)
pI: 5.80 Mw: 28643
%vol: 0.0275323 %od: 0.0157658
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CB6 (csf_human)
pI: 6.24 Mw: 23966
%vol: 0.0223375 %od: 0.0088759
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CB6 (csf_human)
pI: 6.24 Mw: 23966
%vol: 0.0223375 %od: 0.0088759
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C89 (csf_human)
pI: 5.58 Mw: 29653
%vol: 0.026883 %od: 0.0492738
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C89 (csf_human)
pI: 5.58 Mw: 29653
%vol: 0.026883 %od: 0.0492738
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA6 (csf_human)
pI: 5.52 Mw: 25814
%vol: 0.026883 %od: 0.0135608
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA6 (csf_human)
pI: 5.52 Mw: 25814
%vol: 0.026883 %od: 0.0135608
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9X (csf_human)
pI: 7.17 Mw: 26135
%vol: 0.026883 %od: 0.00865199
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9X (csf_human)
pI: 7.17 Mw: 26135
%vol: 0.026883 %od: 0.00865199
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CCJ (csf_human)
pI: 8.48 Mw: 21616
%vol: 0.055714 %od: 0.0360804
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CCJ (csf_human)
pI: 8.48 Mw: 21616
%vol: 0.055714 %od: 0.0360804
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9L (csf_human)
pI: 6.21 Mw: 27057
%vol: 0.182207 %od: 0.167323
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9L (csf_human)
pI: 6.21 Mw: 27057
%vol: 0.182207 %od: 0.167323
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CC4 (csf_human)
pI: 7.03 Mw: 22502
%vol: 0.0931167 %od: 0.101032
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CC4 (csf_human)
pI: 7.03 Mw: 22502
%vol: 0.0931167 %od: 0.101032
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9Z (csf_human)
pI: 5.76 Mw: 26006
%vol: 0.0248051 %od: 0.0121736
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9Z (csf_human)
pI: 5.76 Mw: 26006
%vol: 0.0248051 %od: 0.0121736
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C82 (csf_human)
pI: 5.21 Mw: 30097
%vol: 0.0167532 %od: 0.00878098
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C82 (csf_human)
pI: 5.21 Mw: 30097
%vol: 0.0167532 %od: 0.00878098
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9J (csf_human)
pI: 6.05 Mw: 27124
%vol: 0.0625973 %od: 0.0379812
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9J (csf_human)
pI: 6.05 Mw: 27124
%vol: 0.0625973 %od: 0.0379812
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CB2 (csf_human)
pI: 6.41 Mw: 24144
%vol: 0.145454 %od: 0.122627
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CB2 (csf_human)
pI: 6.41 Mw: 24144
%vol: 0.145454 %od: 0.122627
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CCM (csf_human)
pI: 8.14 Mw: 21464
%vol: 0.143116 %od: 0.132728
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CCM (csf_human)
pI: 8.14 Mw: 21464
%vol: 0.143116 %od: 0.132728
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CBV (csf_human)
pI: 6.82 Mw: 22343
%vol: 0.141558 %od: 0.227086
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CBV (csf_human)
pI: 6.82 Mw: 22343
%vol: 0.141558 %od: 0.227086
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9D (csf_human)
pI: 5.43 Mw: 27327
%vol: 0.0170129 %od: 0.00402786
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9D (csf_human)
pI: 5.43 Mw: 27327
%vol: 0.0170129 %od: 0.00402786
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAJ (csf_human)
pI: 6.42 Mw: 24934
%vol: 0.252466 %od: 0.226957
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAJ (csf_human)
pI: 6.42 Mw: 24934
%vol: 0.252466 %od: 0.226957
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAR (csf_human)
pI: 6.32 Mw: 24750
%vol: 0.0772722 %od: 0.0406583
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAR (csf_human)
pI: 6.32 Mw: 24750
%vol: 0.0772722 %od: 0.0406583
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CB4 (csf_human)
pI: 6.82 Mw: 24085
%vol: 0.114805 %od: 0.0592546
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CB4 (csf_human)
pI: 6.82 Mw: 24085
%vol: 0.114805 %od: 0.0592546
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAZ (csf_human)
pI: 8.42 Mw: 24085
%vol: 0.0758438 %od: 0.0740688
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAZ (csf_human)
pI: 8.42 Mw: 24085
%vol: 0.0758438 %od: 0.0740688
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8K (csf_human)
pI: 5.95 Mw: 29072
%vol: 0.0335063 %od: 0.0421404
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8K (csf_human)
pI: 5.95 Mw: 29072
%vol: 0.0335063 %od: 0.0421404
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C9G (csf_human)
pI: 5.59 Mw: 27259
%vol: 0.0263635 %od: 0.0114435
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C9G (csf_human)
pI: 5.59 Mw: 27259
%vol: 0.0263635 %od: 0.0114435
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CB3 (csf_human)
pI: 6.33 Mw: 23966
%vol: 0.105194 %od: 0.243877
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CB3 (csf_human)
pI: 6.33 Mw: 23966
%vol: 0.105194 %od: 0.243877
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000C8X (csf_human)
pI: 5.33 Mw: 28502
%vol: 0.0274025 %od: 0.0176496
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000C8X (csf_human)
pI: 5.33 Mw: 28502
%vol: 0.0274025 %od: 0.0176496
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CA3 (csf_human)
pI: 6.26 Mw: 25686
%vol: 0.162986 %od: 0.209001
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CA3 (csf_human)
pI: 6.26 Mw: 25686
%vol: 0.162986 %od: 0.209001
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAT (csf_human)
pI: 5.90 Mw: 23906
%vol: 0.0479218 %od: 0.0608487
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAT (csf_human)
pI: 5.90 Mw: 23906
%vol: 0.0479218 %od: 0.0608487
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000CAQ (csf_human)
pI: 6.67 Mw: 23322
%vol: 0.270908 %od: 2.95173
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000CAQ (csf_human)
pI: 6.67 Mw: 23322
%vol: 0.270908 %od: 2.95173
================
*IGLC_HUMAN*
accession n°: P99007
Identification Methods:
* MAPPING: {Gm}
SWISS-2DPAGE Viewer
|
Back to the search engine |
-Get more information by dragging your mouse pointer over any highlighted spot -Click on a highlighted spot to access all its associated protein entries
[estimated location]
Back to the
search engine